tirzepatide manufacturer eli lilly gets nod to launch weight-loss drug in Hong Kong - Bloomberg News Eli Lilly, Walmart Announce Expansion

PWS patients may experience rapid reductions in appetite and food-seeking behavior, which requires careful medical monitoring to ensure safe transitions in eating patterns and caloric intake

Telemedicine and GLP-1s: FDA Enforcement Looms Nice piece in Digital Health Insights by Carrie Pallardy looking at the murky world of direct-to-consumer #telemedicine and GLP-1s, especially companies providing compounded GLP-1s to patients who may not truly need them

This distinction is extremely important because beneficiaries may assume their Medicare Advantage plan or Part D plan is providing the coverage

doi:10.1124/pr.55.1.6

The typical timeline Week 1-2 after starting or increasing dose: This is the highest-risk window

Reference Shen S, Liu B, Fanti C, et al